April 27, 2020 / 4:12 PM / a month ago

BRIEF-Citius Announces Pre-IND Submission To FDA For A Novel Stem Cell Therapy For ARDS In Covid-19

April 27 (Reuters) - Citius Pharmaceuticals Inc:

* CITIUS ANNOUNCES PRE-IND SUBMISSION TO FDA UNDER THE CORONAVIRUS TREATMENT ACCELERATION PROGRAM FOR A NOVEL STEM CELL THERAPY FOR ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN COVID-19

* CITIUS PHARMACEUTICALS INC - COMPANY’S GOAL TO INITIATE CLINICAL TRIAL IN PATIENTS IN 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below